How are Ipratropium Bromide adverse event reports trending over time?
This graph shows volume of adverse events submitted to the FDA by quarter for Ipratropium Bromide, as well as related generic and/or brandname drugs containing the same primary active ingredients. Adverse events are counted if Ipratropium Bromide is flagged as the suspect drug causing the adverse event.
What are the most common Ipratropium Bromide adverse events reported to the FDA?
Drug Ineffective | 965 (6.11%) |
Dyspnoea | 941 (5.96%) |
Dysgeusia | 366 (2.32%) |
Pneumonia | 302 (1.91%) |
Cough | 272 (1.72%) |
Death | 240 (1.52%) |
Chronic Obstructive Pulmonary Disea... | 231 (1.46%) |
Dizziness | 185 (1.17%) |
Asthma | 180 (1.14%) |
Drug Effect Decreased | 164 (1.04%) |
Condition Aggravated | 129 (.82%) |
Show More |
Share/Embed Graph Export Data
This graph shows the top adverse events submitted to the FDA for Ipratropium Bromide, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Ipratropium Bromide is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.
What are the most common Ipratropium Bromide adverse events reported to the FDA?
Respiratory | 2326 (14.73%) |
Therapeutic And Nontherapeutic Effe... | 1329 (8.41%) |
Neurological | 1038 (6.57%) |
Infections - Pathogen Unspecified | 796 (5.04%) |
Bronchial Disorders | 613 (3.88%) |
Cardiac Arrhythmias | 389 (2.46%) |
Gastrointestinal Signs | 367 (2.32%) |
Medication Errors | 352 (2.23%) |
Epidermal And Dermal Conditions | 318 (2.01%) |
Cardiac And Vascular Investigations | 273 (1.73%) |
Fatal Outcomes | 252 (1.6%) |
Show More |
Share/Embed Graph Export Data
This graph shows the top categories of adverse events submitted to the FDA for Ipratropium Bromide, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Ipratropium Bromide is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.
Why are people taking Ipratropium Bromide, according to those reporting adverse events to the FDA?
Chronic Obstructive Pulmonary Disea... | 2899 |
Asthma | 1704 |
Drug Use For Unknown Indication | 1035 |
Product Used For Unknown Indication | 795 |
Dyspnoea | 666 |
Emphysema | 539 |
Show More |
Label | Labeler | Effective |
---|---|---|
Ipratropium Bromide | Mylan Pharmaceuticals Inc. | 15-APR-09 |
Ipratropium Bromide | Nephron Pharmaceuticals Corporation | 09-NOV-09 |
Ipratropium Bromide | Physicians Total Care, Inc. | 31-DEC-09 |
Ipratropium Bromide | Physicians Total Care, Inc. | 05-MAY-10 |
Ipratropium Bromide | Physicians Total Care, Inc. | 05-MAY-10 |
Atroventhfa | Physicians Total Care, Inc. | 28-JUL-10 |
Atrovent | Physicians Total Care, Inc. | 10-SEP-10 |
Atrovent | Physicians Total Care, Inc. | 10-SEP-10 |
Combivent | Physicians Total Care, Inc. | 21-SEP-10 |
Ipratropium Bromide | Rebel Distributors Corp | 29-SEP-10 |
Ipratropium Bromide And Albuterol Sulfate | Physicians Total Care, Inc. | 05-NOV-10 |
Ipratropium Bromide | Bausch & Lomb Incorporated | 03-MAY-11 |
Ipratropium Bromide | Roxane Laboratories, Inc | 18-MAY-11 |
Ipratropium Bromide | Roxane Laboratories, Inc | 18-MAY-11 |
Ipratropium Bromide | Cardinal Health | 24-MAY-11 |
Atrovent | Boehringer Ingelheim Pharmaceuticals, Inc. | 14-JUL-11 |
Atrovent | Boehringer Ingelheim Pharmaceuticals, Inc. | 14-JUL-11 |
Ipratropium Bromide | Bausch & Lomb Incorporated | 01-NOV-11 |
Ipratropium Bromide | Ritedose Pharmaceuticals, LLC | 21-NOV-11 |
Ipratropium Bromide | Rebel Distributors Corp | 13-DEC-11 |
Ipratropium Bromide And Albuterol Sulfate | Cardinal Health | 15-MAY-12 |
Ipratropium Bromide | Cardinal Health | 16-MAY-12 |
Ipratropium Bromide | Mylan Pharmaceuticals Inc. | 01-JUL-12 |
Ipratropium Bromide And Albuterol Sulfate | Cobalt Laboratories | 17-JUL-12 |
Ipratropium Bromide | Preferred Pharmaceuticals, Inc. | 25-JUL-12 |
Combivent Respimat | Boehringer Ingelheim Pharmaceuticals Inc. | 24-AUG-12 |
Atroventhfa | Boehringer Ingelheim Pharmaceuticals Inc. | 24-AUG-12 |
Ipratropium Bromide And Albuterol Sulfate | Eon Labs, Inc. | 31-AUG-12 |
Ipratropium Bromide And Albuterol Sulfate | Mylan Pharmaceuticals Inc. | 31-AUG-12 |
Ipratropium Bromide And Albuterol Sulfate | Nephron Pharmaceuticals Corporation | 04-SEP-12 |
Combivent | Boehringer Ingelheim Pharmaceuticals, Inc. | 20-SEP-12 |
Ipratropium Bromide | Cantrell Drug Company | 13-NOV-12 |
Ipratropium Bromide | Rebel Distributors Corp | 11-DEC-12 |
Ipratropium Bromide And Albuterol Sulfate | Ritedose Pharmaceuticals, LLC | 13-DEC-12 |
Ipratropium Bromide And Albuterol Sulfate | Teva Pharmaceuticals USA Inc | 18-DEC-12 |
Ipratropium Bromide And Albuterol Sulfate | Watson Laboratories, Inc. | 08-FEB-13 |
Ipratropium Bromide | Preferred Pharmaceuticals, Inc | 22-FEB-13 |
Ipratropium Bromide And Albuterol Sulfate | Mylan Pharmaceuticals, Inc. | 25-FEB-13 |
Ipratropium Bromide | Watson Laboratories, Inc. | 04-APR-13 |
Ipratropium Bromide | Sandoz Inc. | 10-APR-13 |
Ipratropium Bromide | Cardinal Health | 25-APR-13 |
What Ipratropium Bromide safety concerns are being reported by doctors and researchers in the medical literature?
This report contains aggregated drug side effects and adverse events for Ipratropium Bromide. The data has been pulled from the United States Food and Drug Administration's (US FDA) Adverse Event Reporting System (AERS), a database containing more than 4,000,000 adverse event reports.
DrugCite expands your query using the Unified Medical Language System (UMLS) to include generic drugs and primary active ingredients. While the core of DrugCite's advanced drug filtering algorithm is based on the industry standard UMLS, DrugCite's proprietary filtering system also includes dozens of additional steps to reconcile malformed drug names in the FDA's data.
DrugCite only counts a drug if the submitter of the adverse event indicates that the drug is suspected to have caused the adverse event.
Depending on how the data is aggregated, different counts may occur. When someone submits an adverse event to the FDA, the submitter can attribute multiple adverse events to one or more drugs. For example, an individual taking Paxil could submit the adverse events "anxiety" and "suicidal ideation" for the same individual safety report (ISR). This means when DrugCite aggregates by adverse event, two distinct adverse events are counted in the adverse event graph; once for "anxiety" and again for "suicidal ideation". However, when DrugCite aggregates by individual safety reports irrespective of the details of the adverse events contained within the safety report, the report is only counted once.
Share your experience with Ipratropium Bromide.